Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,318.20 +138.38 0.91%
S&P 500 1,651.81 +12.77 0.78%
Nasdaq 3,482.18 +30.05 0.87%
Ticker Volume Price Price Delta
STOXX 50 2,700.93 -1.76 -0.07%
FTSE 100 6,374.21 +43.72 0.69%
DAX 8,229.51 +13.78 0.17%
Ticker Volume Price Price Delta
Nikkei 13,237.40 +230.14 1.77%
Hang Seng 21,225.90 -0.02 0.00%
S&P/ASX 200 4,834.60 +20.25 0.42%

Metabolix Has Record Drop After ADM Ends Bio-Plastics Venture

Metabolix Inc. (MBLX), the Massachusetts maker of plant-derived chemicals, had its biggest intraday decline after Archer Daniels Midland Co. (ADM) unexpectedly ended a joint venture that made bio-plastics.

Metabolix, based in Cambridge, dropped 55 percent to $2.68 at 9:33 a.m. in New York, the largest fall since the company began trading in 2006.

The companies’ alliance will end Feb. 8 because its financial returns are “too uncertain,” Decatur, Illinois-based ADM said in a statement yesterday. The company will dissolve Telles LLC, created with Metabolix to sell the bio-plastic Mirel, while retaining an ADM factory in Clinton, Iowa, where the corn-based resin was made.

Metabolix didn’t expect the cancellation and will start evaluating options for commercializing its bio-plastics technology, including searching for a new partner, Chief Executive OfficerRichard Eno said yesterday in a conference call.

To contact the reporter on this story: Jack Kaskey in Houston at jkaskey@bloomberg.net

To contact the editor responsible for this story: Simon Casey at scasey4@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.

Sponsored Link